Skip to content

Distance Ischemic Preconditioning in Acute Mild-Moderate Ischemic Stroke (DIPIS): a Parallel Controlled, Single Blind and Randomized Clinical Study

Distance Ischemic Preconditioning in Acute Mild-Moderate Ischemic Stroke (DIPIS): a Parallel Controlled, Single Blind and Randomized Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17012011
Enrollment
Unknown
Registered
2017-07-17
Start date
2017-08-01
Completion date
Unknown
Last updated
2018-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral infarction

Interventions

training group:distance ischemic preconditioning training
control group:distance ischemic preconditioning training without pressor

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Aged 18 to 80 years; 2) Patients with acute cerebral infarction within 48 hours; 3) NIHSS 1 to 10; 4) Patients with the first onset or previous cerebral infarction have not had the disorder of limb paralysis,and no impact on this NIHSS score; mRS=1; 5) Consent to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. This onset received thrombolytic therapy; 2. Hemorrhagic stroke or mixed stroke; 3. Cerebral arteriovenous malformation or intracranial tumor; 4. Cardiogenic cerebrovascular disease; 5. Uncontrollable high blood pressure, combined with severe infection or liver and kidney, blood system disease and other patients; 6. Previous history of cerebral hemorrhage; 7. Retinal hemorrhage or internal bleeding occurs within 30 days; 8. Patients with distance ischemic contraindications, severe soft tissue injury, fracture or blood vessel injury, distal upper limb peripheral vascular disease, etc; 9. Pregnant or lactating women; 10. The researchers found it inappropriate to participate in the study.

Design outcomes

Primary

MeasureTime frame
The progression of stroke deteriorated within 90 days;

Secondary

MeasureTime frame
NIHSS and mRS scores improvement within 90 days;Other vascular and death events within 90 days;Changes of blood biochemical indexes before and after treatment;

Countries

China

Contacts

Public ContactDingbo Tao

The First Affiliated Hospital of Dalian Medical University

db_tao@126.com+86 13322285679

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026